Table 1.
Demographic and clinical characteristics of systemic sclerosis (SSc) patients
| Variables | SSc (n = 20) | CS (n = 20) | ||
|---|---|---|---|---|
| Demographics | ||||
| Age (years)a | 44.4 ±17.7 | 39.6 ±14.6 | ||
| Genderb | ||||
| Female | 80 (16) | 75 (15) | ||
| Male | 20 (4) | 25 (5) | ||
| BMI (kg/m2)a | 24.4 ±3.9 | 26.9 ±4.0 | ||
| Clinical assessment | ||||
| Disease subtypeb | ||||
| lcSSc | 70 (14) | – | ||
| dcSSc | 30 (6) | – | ||
| Disease evolution (years)c | 4 (0.5-20) | – | ||
| Clinical manifestationsb | ||||
| Skin thickening | 95 (19) | – | ||
| Joint contractures | 95 (19) | – | ||
| Puffy fingers | 75 (15) | – | ||
| Raynaud’s phenomenon | 70 (14) | – | ||
| Telangiectasia | 50 (10) | – | ||
| Clinical evaluation | ||||
| Spanish HAQ-DI, 0-3 scalea | 0.46 ± 0.44 | – | ||
| mRSS51c | 6 (0-30) | – | ||
| Drug treatmentb | ||||
| None | 55 (11) | 100 (20) | ||
| Prednisone | 35 (7) | – | ||
| Methotrexate | 35 (7) | – | ||
| Chloroquine | 15 (3) | – | ||
a
Data presented as mean ± standard deviation. bData presented as percentage and n. cData presented as median (p5-p95). SSc – systemic sclerosis, BMI – body mass index, dcSSc – diffuse cutaneous systemic sclerosis, lcSSc – limited cutaneous systemic sclerosis, mRSS – modified Rodnan skin score, Spanish HAQ-DI – the Spanish version of Health Assessment Questionnaire Disability Index.